Feedback (FDBK) – Appointment of Joint Broker
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to announce the appointment of Northland Capital Partners Limited as joint broker to the Company with immediate effect. For further information contact: Feedback plc Alastair Riddell Tel: 01954 718072 Allenby Capital Limited (Nominated Adviser and Joint Broker) David Worlidge / James Thomas Tel: 020 […]
Brand CEO Alan Green discusses Feedback (FDBK), Advanced Oncotherapy (AVO) & Defenx (DFX) on VOX Markets podcast
Brand CEO Alan Green discusses Feedback (FDBK), Advanced Oncotherapy (AVO) & Defenx (DFX) with Justin Waite on the VOX Markets podcast. The interview is 35 minutes, 29 seconds in.
4 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
Presentation at forthcoming European Congress of Radiology (March 1-5 2017) Provided by University of Brescia. Presentation Details Presentation Title: Correlation between locally advanced HPV positive oropharyngeal squamous cell carcinoma and quantitative MRI parameters Author Block: M. Leali, E. Tononcelli, E. Lleshaj, A. Grammatica, M. Ravanelli, D. Farina, R. Maroldi; Brescia/IT (The presenting author is underlined.) Disclosure Block: M. Leali: None. E. Tononcelli: None. E. […]
3 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
Presentation at forthcoming European Congress of Radiology (March 1-5 2017) Provided by University of Brescia. Presentation Details Presentation Title: CT texture analysis as a predictor of response to therapy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors Author Block: G. Bonera, G. Agazzi, M. Ravanelli, D. Farina, V. Ferrari, A. […]
Feedback Plc (FDBK) – Interim Report for six months ended 30 November 2016
Feedback plc – Interim Report for the six months ended 30 November 2016 Chairman’s Statement We are pleased to present the interim results for the six months ended 30 November 2016. Revenue for the six months period was £203,000 (2015: £225,000) and the loss after tax was £126,000 (2015: Loss £143,000). The loss before interest, tax […]
TexRAD paper wins registrars prize at ARGANZ 2017 meeting – Feedback Plc (FDBK)
Many congratulations to Raj Deva for winning the registrar’s prize for his TexRAD paper. The paper, entitled “Radiogenomics in clear cell real cell carcinoma: Initial evidence for associations between CT heterogeneity, gene mutation count and survival” was presented by Raj at the recently concluded Abdominal Radiology Group Australia and New Zealand annual meeting 11-12 February, 2017, Sydney, Australia […]
2 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
Presentation at forthcoming European Congress of Radiology (March 1-5 2017) Provided by University of Brescia. Presentation Details Presentation Title: CT texture analysis in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors: prediction of survival Author Block: J. Cardinale, V. Bettoni, G. Agazzi, M. Ravanelli, E. Roca, D. Farina, A. Berruti, R. Maroldi; Brescia/IT (The presenting author is underlined.) Disclosure […]
1- Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
Presentation at forthcoming European Congress of Radiology (March 1-5 2017) Provided by Oslo University Hospital. Presentation Title: Texture analysis on diffusion-tensor imaging: discriminating glioblastomas from single brain metastasis Author Block: K. Skogen1, A. Schulz1, E. Helseth1, J.B. Dormagen1, B. Ganeshan2, A. Server1; 1Oslo/NO, 2London/GB (The presenting author is underlined.) Disclosure Block: K. Skogen: Shareholder; Yes. Speaker; Yes. A. Schulz: None. E. Helseth: None. J.B. Dormagen: None. B. Ganeshan: Shareholder; Yes. A. Server: None. […]
Feedback (FDBK) – Two recently published papers on CT texture analysis
Feedback (FDBK) – Two recently published papers on CT texture analysis. Source 1) CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib. […]
Brand CEO Alan Green talks Angus Energy (ANGS), Feedback (FDBK), Advanced Onco (AVO) & Swallowfield (SWL) on the VOX Markets podcast
Brand CEO Alan Green talks Angus Energy (ANGS), Feedback (FDBK), Advanced Onco (AVO) & Swallowfield (SWL) with Justin Waite on the VOX Markets podcast. Interview starts at 46 minutes 20 seconds.